A novel mutation in bruton tyrosine kinase confers acquired resistance to ibrutinib (PCI-32765) in chronic lymphocytic leukemia Meeting Abstract


Authors: Cheng, S.; Lu, P.; Setty, M.; Perez, A.; Guo, A.; Racchumi, J.; Venkataraman, K.; Ma, J.; Coleman, M.; Leslie, C.; Wang, Y.
Abstract Title: A novel mutation in bruton tyrosine kinase confers acquired resistance to ibrutinib (PCI-32765) in chronic lymphocytic leukemia
Meeting Title: 2013 Annual Meeting of the Association for Molecular Pathology (AMP)
Journal Title: Journal of Molecular Diagnostics
Volume: 15
Issue: 6
Meeting Dates: 2013 Nov 14-16
Meeting Location: Phoenix, AZ
ISSN: 1525-1578
Publisher: Elsevier Science, Inc.  
Date Published: 2013-11-01
Start Page: 859
Language: English
ACCESSION: WOS:000326668000076
PROVIDER: Thomson Reuters Web of Knowledge
PROVIDER: wos
DOI: 10.1016/S1525-1578(13)00181-5
Notes: Meeting Abstract: H08 -- Annual Meeting of the Association-for-Molecular-Pathology (AMP) -- NOV 14-16, 2013 -- Phoenix, AZ -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christina Leslie
    187 Leslie
  2. Manu Setty
    35 Setty
  3. Alexandar Reinaldo Perez
    14 Perez